scispace - formally typeset
E

Esther Fuentes

Researcher at Universidad Miguel Hernández de Elche

Publications -  36
Citations -  3719

Esther Fuentes is an academic researcher from Universidad Miguel Hernández de Elche. The author has contributed to research in topics: Estrogen receptor & Receptor. The author has an hindex of 26, co-authored 35 publications receiving 3450 citations. Previous affiliations of Esther Fuentes include King's College London.

Papers
More filters
Journal ArticleDOI

The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance

TL;DR: The results in this article show that the widespread environmental contaminant bisphenol-A (BPA) imitates 17β-estradiol (E2) effects in vivo on blood glucose homeostasis through genomic and nongenomic pathways.
Journal ArticleDOI

Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β

TL;DR: It is shown here that xenoestrogens act at the genomic level by binding to intracellular estrogen receptors and trigger nongenomic effects in pancreatic beta cells, and an outline of the membrane receptor involved in rapidxenoestrogen actions is provided.
Journal ArticleDOI

Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways.

TL;DR: The purpose of the present review is to analyze with substantiated scientific evidence the strong estrogenic activity of BPA when it acts through alternative mechanisms of action at least in certain cell types.
Journal ArticleDOI

Low Doses of Bisphenol A and Diethylstilbestrol Impair Ca2+ Signals in Pancreatic α-Cells through a Nonclassical Membrane Estrogen Receptor within Intact Islets of Langerhans

TL;DR: It is shown that the endocrine disruptors bisphenol A (BPA) and diethylstilbestrol (DES) suppressed low-glucose–induced intracellular calcium ion ([Ca2+]i) oscillations in α-cells, the signal that triggers glucagon secretion.
Journal ArticleDOI

Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell

TL;DR: Using quantitative real-time PCR and immunocytochemistry, it is demonstrated the existence of both CB1 and CB2 receptors in the endocrine pancreas and this effect may be a new component involved in the orexigenic effect of endocannabinoids and constitutes a potential target for pharmacologic manipulation of the energy balance.